RETRACTION: Systematic Evaluation of KCNQ1 variant using ACMG/AMP Guidelines and Risk Stratification in Long QT Syndrome Type 1

被引：1
|
作者：
Kashiwa, A.
Aiba, T.
Makimoto, H.
Shimamoto, K.
Yamagata, K.
Kamakura, T.
Wada, M.
Miyamoto, K.
Inoue-Yamada, Y.
Ishibashi, K.
Noda, T.
Nagase, S.
Miyazaki, A.
Sakaguchi, H.
Shiraishi, I
Yagihara, N.
Watanabe, H.
Aizawa, Y.
Makiyama, T.
Itoh, H.
Hayashi, K.
Yamagishi, M.
Sumitomo, N.
Yoshinaga, M.
Morita, H.
Ohe, T.
Miyamoto, Y.
Makita, N.
Yasuda, S.
Kusano, K.
Ohno, S.
Horie, M.
Shimizu, W.
机构：
来源：
CIRCULATION-GENOMIC AND PRECISION MEDICINE | 2021年 / 14卷 / 02期
关键词：
D O I：
10.1161/HCG.0000000000000079
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：271 / 271
页数：1
相关论文
共 50 条
  • [1] Systematic Evaluation of KCNQ1 variant using ACMG/AMP Guidelines and Risk Stratification in Long QT Syndrome Type 1
    Kashiwa, A.
    Aiba, T.
    Makimoto, H.
    Yagihara, N.
    Ohno, S.
    Makiyama, T.
    Hayashi, K.
    Itoh, H.
    Sumitomo, N.
    Yoshinaga, M.
    Morita, H.
    Makita, N.
    Kusano, K.
    Horie, M.
    Shimizu, W.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 345 - 345
  • [2] Systematic Evaluation of KCNQ1 variant using ACMG/AMP Guidelines and Risk Stratification in Long QT Syndrome Type 1: Expression of Concern (Expression of Concern of 2020)
    Kashiwa, A.
    [J]. CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2020, 13 (06): : 742 - 742
  • [3] Genetic characterization of KCNQ1 variants improves risk stratification in type 1 long QT syndrome patients
    Morgat, Charles
    Fressart, Veronique
    Porretta, Alessandra Pia
    Neyroud, Nathalie
    Messali, Anne
    Temmar, Yassine
    Algalarrondo, Vincent
    Surget, Elodie
    Bloch, Adrien
    Leenhardt, Antoine
    Denjoy, Isabelle
    Extramiana, Fabrice
    [J]. EUROPACE, 2024, 26 (06):
  • [4] KCNQ1 Antibodies for Immunotherapy of Long QT Syndrome Type 2
    Maguy, Ange
    Kucera, Jan P.
    Wepfer, Jonas P.
    Forest, Virginie
    Charpentier, Flavien
    Li, Jin
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (17) : 2140 - 2152
  • [5] Impaired ion channel function related to a common KCNQ1 mutation - Implications for risk stratification in long QT syndrome 1
    Aidery, Parwez
    Kisselbach, Jana
    Schweizer, Patrick A.
    Becker, Ruediger
    Katus, Hugo A.
    Thomas, Dierk
    [J]. GENE, 2012, 511 (01) : 26 - 33
  • [6] Suppression-Replacement KCNQ1 Gene Therapy for Type 1 Long QT Syndrome
    Dotzler, Steven M.
    Kim, C. S. John
    Gendron, William A. C.
    Zhou, Wei
    Ye, Dan
    Bos, J. Martijn
    Tester, David J.
    Barry, Michael A.
    Ackerman, Michael J.
    [J]. CIRCULATION, 2021, 143 (14) : 1411 - 1425
  • [7] LONG QT SYNDROME:AN ENTIRE FAMILY WITH KCNQ1 MUTATION
    Di Domenico, A.
    De Carolis, B.
    De Raffele, M.
    Vitali, F.
    Balla, C.
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 (SUPPL C)
  • [8] A novel stop-gain pathogenic variant in the KCNQ1 gene causing long QT syndrome 1
    Kalayinia, Samira
    Dalili, Mohammad
    Pourirahim, Maryam
    Maleki, Majid
    Mahdieh, Nejat
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [9] A novel stop-gain pathogenic variant in the KCNQ1 gene causing long QT syndrome 1
    Samira Kalayinia
    Mohammad Dalili
    Maryam Pourirahim
    Majid Maleki
    Nejat Mahdieh
    [J]. European Journal of Medical Research, 28
  • [10] Association of the P441L KCNQ1 variant with severity of long QT syndrome and risk of cardiac events
    Lu, Haoyang
    Ding, Wen
    Xiao, Hui
    Dai, Manyu
    Xue, Yangcheng
    Jia, Zhuoran
    Guo, Jie
    Wu, Mengzuo
    Shen, Bing
    Zhao, Ren
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
12345